Zydus Lifesciences Ltd.

BSE: 532321 | NSE: ZYDUSLIFE

Mid Cap | Pharmaceuticals & Drugs

930.25

1.40 (0.15%)

< Home < Back

Zydus Lifesciences Ltd. News

>>

Zydus Lifesciences gains on getting gets final approval from USFDA for Lenalidomide Capsules

>>

Zydus Lifesciences gets final approval from USFDA for Lenalidomide Capsules

>>

Zydus Lifesciences’ arm gets final approval, 180 days shared exclusivity from USFDA for Cariprazine Capsules

>>

Zydus Lifesciences informs about loss of share certificate

>>

Zydus Lifesciences surges on acquiring rights to market MonoFerric injections in India, Nepal

>>

Zydus Lifesciences informs about press release

>>

Zydus Lifesciences acquires rights to market MonoFerric injections in India, Nepal

>>

Zydus Lifesciences gains on getting positive Proof-of-Concept in Phase 2 clinical study of ‘ZYIL1’

>>

Zydus Lifesciences gets positive Proof-of-Concept in Phase 2 clinical study of ‘ZYIL1’

>>

Zydus Lifesciences recalls 1,116 boxes of Fulvestrant Injection in US market

<< < 59 60 61 ...168 > >>